Which gelatin source — bovine, porcine or fish — is right for pharma products?

Beyond Biopharma · Pharmaceutical Gelatin FAQ

Short answer: The right source depends on the product's market, religious and allergen needs more than on gelatin chemistry. Bovine gelatin is a common general reference source, can be produced to halal or kosher certification, and requires BSE risk documentation, which some buyers treat as an administrative burden. Porcine gelatin is generally economical but is excluded where religious or market rules bar pig material. Fish gelatin offers flexibility for buyers who must avoid pig material and can be certified per relevant rules, but it is more costly, carries a fish-allergen consideration, and its gel tends to melt at a lower temperature, which can matter for certain dosage forms.

Chemistry is similar; suitability differs

All gelatin — whatever the animal — is partly hydrolysed collagen and shares the same underlying gelling chemistry, so the source choice is rarely about which one "works better" in a universal sense. It is about which material is acceptable and practical for a particular product, market and supply chain. The three mainstream pharmaceutical sources each carry a characteristic profile of behaviour, certification reach and process implications that a formulator and buyer weigh together.

Bovine gelatin

Bovine (cattle) gelatin is one of the most widely used and is often treated as a general reference source in pharmaceutical applications. Its main characteristics:

• A broad, well-characterised catalogue across capsule, softgel and coating uses.
• Can be produced to halal and kosher certification where slaughter and sourcing rules are fully controlled.
• Because it is cattle-derived, it requires BSE risk documentation and sourcing control tied to the raw-material origin.

For buyers whose market has no constraint on cattle material, bovine gelatin is often the straightforward first choice, with the BSE documentation set being the principal added administrative consideration.

Porcine gelatin

Porcine (pig) gelatin is generally among the more economical sources and processes reliably across common pharmaceutical uses. Its profile is defined mainly by its limitation:

• Economical and reliable in established hard- and soft-cap application.
• Simply not acceptable where religious rules (notably halal constraints in parts of the market) or market requirements bar pig-derived material.

Where pig material is acceptable to the target market, porcine gelatin is a practical, cost-effective mainstay. Where it is not — for example in many Muslim-majority and halal-defined markets — it is excluded from consideration entirely, which is why the market decision usually comes before the cost comparison.

Fish gelatin

Fish gelatin is chosen mainly for what it avoids and offers, rather than for being the cheapest option:

• Flexible where buyers must avoid pig material and wish to sidestep cattle-related BSE documentation.
• Can be certified to fit relevant religious rules in many cases, which broadens market acceptance.
• Typically more costly than porcine or bovine equivalents.
• Carries a fish-allergen consideration that must be communicated for sensitive populations.
• Its gel often has a lower melting point, which can matter for certain dosage forms and storage behaviour.

Fish gelatin therefore suits products targeting markets or consumers where mammalian material is undesirable, provided its higher cost, allergen implications and melting behaviour can be accommodated.

A comparison at a glance

How buyers decide

A practical decision sequence mirrors the wider grade-selection framework: settle the market and religious requirements first, since those dictate whether a source is even eligible, then check allergen and labelling considerations, then confirm the source's process behaviour suits the dosage form and shelf life. Where more than one source is eligible, the final choice weighs cost, documentation burden and supply security. Always confirm current certification and sourcing specifics with the supplier and against the requirements of the destination market, as source-related rules and market expectations can change.

No single "best" source

There is no objectively best source across all pharmaceutical products; there is only the source that best fits the specific product's market, religious, allergen and tolerance needs. Bovine gelatin suits many general markets, porcine suits markets where cost is a driver and pig material is accepted, and fish gelatin serves those who must avoid mammalian material. Weighing these against your own product requirements is the reliable way to choose.